share_log

Syndax Pharmaceuticals Q4 EPS $(0.44) Beats $(0.49) Estimate, Sales $380.00K Beat $200.00K Estimate

Syndax Pharmaceuticals Q4 EPS $(0.44) Beats $(0.49) Estimate, Sales $380.00K Beat $200.00K Estimate

Syndax制药第四季度每股收益0.44美元超过0.49美元预期,销售额380.00K美元超过200.00K美元预期
Benzinga Real-time News ·  2021/03/09 05:11

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.49) by 10.2 percent. This is unchanged from the same period last year. The company reported quarterly sales of $380.00 thousand which beat the analyst consensus estimate of $200.00 thousand by 90.00 percent. This is the same as the same period last year.

Syndax制药公司(纳斯达克:SNDX)公布季度亏损(0.44美元),比分析师普遍预期的(0.49美元)高出10.2%。这与去年同期持平。该公司公布季度销售额为380万美元,比分析师普遍预期的20万美元高出90.00%。这与去年同期持平。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发